Year-over-year articles
AGILERA PHARMA AS
5 crawlable comparisons of consecutive annual reports.
Full company analysis · Org.nr 928 041 069
Weaker earnings, fresh owner capital
Comparing Årsregnskap 2025 with 2024 for AGILERA PHARMA AS. Revenue 357.64m NOK → 352.52m NOK (-1.4%). Net result -34.75m NOK → -69.62m NOK. Equity 15.02m…
Grew 122879% on revenue, weaker earnings
Comparing Årsregnskap 2024 with 2023 for AGILERA PHARMA AS. Revenue 290.8k NOK → 357.64m NOK (+122879.0%). Net result -8.32m NOK → -34.75m NOK. Equity…
Grew 43763% on revenue, weaker earnings, fresh owner capital
Comparing Årsregnskap 2023 with 2022 for AGILERA PHARMA AS. Revenue 663 NOK → 290.8k NOK (+43763.5%). Net result -1 200 NOK → -8.32m NOK. Equity 23.2k NOK →…
Slipped into loss
Comparing Årsregnskap 2022 with 2021 for AGILERA PHARMA AS. Net result 0 NOK → -1 200 NOK. Equity 24.4k NOK → 23.2k NOK.
First published accounts
First year in the published series for AGILERA PHARMA AS (2021). No prior-year comparative in this dataset.